| Systematic (IUPAC) name | |
|---|---|
| 1-(2-Dimethylaminoethyl)-8,9-dihydropyrano[3,2-e]indole | |
| Clinical data | |
| Pregnancy cat. | ? |
| Legal status | ? |
| Identifiers | |
| CAS number | 135360-97-3 |
| ATC code | ? |
| PubChem | CID 15011385 |
| Chemical data | |
| Formula | C15H20N2O |
| Mol. mass | 244.331 g/mol |
| SMILES | eMolecules & PubChem |
| |
|
1-(2-Dimethylaminoethyl)dihydropyrano(3,2-e)indole (4,5-DHP-DMT) is a tricyclic tryptamine derivative which acts as a potent and reasonably selective partial agonist for the serotonin receptor 5-HT2A, with a Ki of 17.0 nM, and moderate selectivity over related serotonin receptors. It has lower 5-HT2 affinity and efficacy than the related compound AL-37350A, but higher lipophilicity.[1][2]
|
|||||
| This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it. |
This entry is from Wikipedia, the leading user-contributed encyclopedia. It may not have been reviewed by professional editors (see full disclaimer)